Enovis CorporationEnovis CorporationEnovis Corporation

Enovis Corporation

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.59 B‬USD
−2.17USD
‪−48.78 M‬USD
‪1.71 B‬USD
‪55.15 M‬
Beta (1Y)
1.08
Employees (FY)
‪6.55 K‬
Change (1Y)
−250 −3.68%
Revenue / Employee (1Y)
‪260.64 K‬USD
Net income / Employee (1Y)
‪−8.30 K‬USD

About Enovis Corporation


CEO
Matthew L. Trerotola
Website
Headquarters
Wilmington
Founded
1995
FIGI
BBG000C5Z443
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ENOV is 46.42 USD — it has decreased by −3.01% in the past 24 hours. Watch Enovis Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Enovis Corporation stocks are traded under the ticker ENOV.
ENOV stock has risen by 11.64% compared to the previous week, the month change is a 19.86% rise, over the last year Enovis Corporation has showed a −4.29% decrease.
We've gathered analysts' opinions on Enovis Corporation future price: according to them, ENOV price has a max estimate of 75.00 USD and a min estimate of 50.00 USD. Watch ENOV chart and read a more detailed Enovis Corporation stock forecast: see what analysts think of Enovis Corporation and suggest that you do with its stocks.
ENOV reached its all-time high on Apr 20, 2022 with the price of 72.13 USD, and its all-time low was 38.27 USD and was reached on Oct 8, 2024. View more price dynamics on ENOV chart.
See other stocks reaching their highest and lowest prices.
ENOV stock is 4.20% volatile and has beta coefficient of 1.08. Track Enovis Corporation stock price on the chart and check out the list of the most volatile stocks — is Enovis Corporation there?
Today Enovis Corporation has the market capitalization of ‪2.59 B‬, it has increased by 6.37% over the last week.
Yes, you can track Enovis Corporation financials in yearly and quarterly reports right on TradingView.
Enovis Corporation is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ENOV earnings for the last quarter are 0.73 USD per share, whereas the estimation was 0.62 USD resulting in a 18.52% surprise. The estimated earnings for the next quarter are 0.92 USD per share. See more details about Enovis Corporation earnings.
Enovis Corporation revenue for the last quarter amounts to ‪505.22 M‬ USD, despite the estimated figure of ‪504.44 M‬ USD. In the next quarter, revenue is expected to reach ‪555.40 M‬ USD.
ENOV net income for the last quarter is ‪−31.52 M‬ USD, while the quarter before that showed ‪−18.64 M‬ USD of net income which accounts for −69.12% change. Track more Enovis Corporation financial stats to get the full picture.
No, ENOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has ‪6.55 K‬ employees. See our rating of the largest employees — is Enovis Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Enovis Corporation EBITDA is ‪235.23 M‬ USD, and current EBITDA margin is 11.00%. See more stats in Enovis Corporation financial statements.
Like other stocks, ENOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enovis Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enovis Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enovis Corporation stock shows the sell signal. See more of Enovis Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.